Coronary heart disease and body fat distribution

Current Atherosclerosis Reports

Volumn 12, Issue 2, 2010, Pages 125-133

  Canoy, Dexter ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Abdominal obesity; Coronary heart disease; Fat distribution

Indexed keywords

ANTHROPOMETRIC PARAMETERS; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; GLUCOSE HOMEOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID STORAGE; METABOLIC DISORDER; NONHUMAN; OBESITY; REVIEW; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; BLOOD; COMPLICATION; CORONARY DISEASE; DISEASE COURSE; RISK FACTOR;

BODY FAT DISTRIBUTION; CORONARY DISEASE; DISEASE PROGRESSION; FATTY ACIDS, NONESTERIFIED; HUMANS; OBESITY, ABDOMINAL; RISK FACTORS;

FATTY ACID;

EID: 77953540239     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0092-9     Document Type: Review

References (62)

1. World Health Organization: Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Geneva: World Health Organization; 2000.
2. Bjorntorp P: "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990, 10:493-496. (Pubitemid 20220571)
3. Despres JP, Lemieux I, Bergeron J, et al.: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
4. Despres JP, Prud'homme D, Pouliot MC, et al.: Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991, 54:471-477.
5. National Institutes of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998, 6:51S-209S.
6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
7. National Insititute for Health and Clinical Effectiveness: Obesity: Guidance on the Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children (Report number CG43). London: National Institute for Health and Clinical Excellence; 2006.
8. Health Canada: Canadian Guidelines for Body Weight Classification in Adults (Publication ID 4645). Ottawa, Canada: Health Canada Publications Centre; 2003.
9. de Koning L, Merchant AT, Pogue J, Anand SS: Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007, 28:850-856. This is the first (and so far only) metaanalysis that quantified the risk for CVD associated with higher waist circumference and higher waist-hip ratio.
10. Canoy D: Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol 2008, 23:591-598. This is a systematic review of prospective studies examining the association between waist circumference and waist-hip ratio with CHD.
11. Thomas EL, Saeed N, Hajnal JV, et al.: Magnetic resonance imaging of total body fat. J Appl Physiol 1998, 85:1778-1785.
12. Fox CS, Gona P, Hoffmann U, et al.: Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation 2009, 119:1586-1591.
13. Levine JA, Ray A, Jensen MD: Relation between chubby cheeks and visceral fat. N Engl J Med 1998, 339:1946-1947.
14. Kelley DE: Skeletal muscle triglycerides: an aspect of regional adiposity and insulin resistance. Ann N Y Acad Sci 2002, 967:135-145.
15. Arner P: Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 2005, 19:471-482.
16. Fried SK, Russell CD, Grauso NL, Brolin RE: Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993, 92:2191-2198.
17. Fontana L, Eagon JC, Trujillo ME, et al.: Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007, 56:1010-1013.
18. Peverill RE, Teede HJ, Malan E, et al.: Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clin Sci (Lond) 2007, 113:383-391.
19. Kelley DE, Thaete FL, Troost F, et al.: Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000, 278:E941-E948.
20. Tan GD, Goossens GH, Humphreys SM, et al.: Upper and lower body adipose tissue function: a direct comparison of fat mobilization in humans. Obes Res 2004, 12:114-118.
21. Nielsen S, Guo Z, Johnson CM, et al.: Splanchnic lipolysis in human obesity. J Clin Invest 2004, 113:1582-1588.
22. Jensen MD: Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 2008, 93:S57-S63. This is an important review of the role of adipose tissue in regulating fatty acid metabolism. It highlights studies that are associated with direct quantification of fatty acid concentration in portal circulation in vivo.
23. Frayn KN: Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002, 45:1201-1210.
24. Gavrilova O, Marcus-Samuels B, Graham D, et al.: Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000, 105:271-278.
25. Kim JY, van de Wall E, Laplante M, et al.: Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007, 117:2621-2637. This is a landmark study showing that expansion of the subcutaneous fat in obese mice led to an improvement and normalization of the adverse metabolic profile despite weight gain.
26. Simha V, Garg A: Lipodystrophy: lessons in lipid and energy metabolism. Curr Opin Lipidol 2006, 17:162-169.
27. Mohammed BS, Cohen S, Reeds D, et al.: Long-term effects of large-volume liposuction on metabolic risk factors for coronary heart disease. Obesity (Silver Spring) 2008, 16:2648-2651.
28. Adams M, Montague CT, Prins JB, et al.: Activators of peroxisome proliferator-activated receptor gamma have depotspecific effects on human preadipocyte differentiation. J Clin Invest 1997, 100:3149-3153.
29. Danforth E Jr: Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 2000, 26:13.
30. Fabbrini E, Magkos F, Mohammed BS, et al.: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 2009, 106:15430-15435. This study highlights the importance of intrahepatic fat as the potential underlying pathology associated with abdominal obesity in humans. The results of this study have indeed questioned the centrality of visceral fat as the key player in the metabolic consequences of abdominal obesity.
31. Carroll JF, Chiapa AL, Rodriquez M, et al.: Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity (Silver Spring) 2008, 16:600-607.
32. Herrera VM, Casas JP, Miranda JJ, et al.: Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease. Int J Obes (Lond) 2009, 33:568-576.
33. Ghandehari H, Le V, Kamal-Bahl S, et al.: Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obes (Lond) 2009, 33:239-248.
34. Vague J: The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956, 4:20-34.
35. Larsson B, Svardsudd K, Welin L, et al.: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984, 288:1401-1404. (Pubitemid 14088431)
36. Lapidus L, Bengtsson C, Larsson B, et al.: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984, 289:1257-1261. (Pubitemid 15217605)
37. Cameron AJ, Dunstan DW, Owen N, et al.: Health and mortality consequences of abdominal obesity: evidence from the AusDiab study. Med J Aust 2009, 191:202-208.
38. Bradshaw PJ, Alfonso HS, Finn JC, et al.: Coronary heart disease events in Aboriginal Australians: incidence in an urban population. Med J Aust 2009, 190:583-586.
39. Dhaliwal SS, Welborn TA: Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores. Am J Cardiol 2009, 103:1403-1407.
40. Parker ED, Pereira MA, Stevens J, Folsom AR: Association of hip circumference with incident diabetes and coronary heart disease: the Atherosclerosis Risk in Communities study. Am J Epidemiol 2009, 169:837-847.
41. Page JH, Rexrode KM, Hu F, et al.: Waist-height ratio as a predictor of coronary heart disease among women. Epidemiology 2009, 20:361-366.
42. Pischon T, Boeing H, Hoffmann K, et al.: General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008, 359:2105-2120. As part of a collaborative cohort study across Europe, this article shows findings on the importance of fat distribution as a risk factor for all-cause and cause-specific mortality. To date, this study involves the largest number of cohort participants that addressed health consequences of abdominal obesity.
43. Yang L, Kuper H, Weiderpass E: Anthropometric characteristics as predictors of coronary heart disease in women. J Intern Med 2008, 264:39-49.
44. Gelber RP, Gaziano JM, Orav EJ, et al.: Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 2008, 52:605-615.
45. Folsom AR, Stevens J, Schreiner PJ, McGovern PG: Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites. Atherosclerosis Risk in Communities Study Investigators. Am J Epidemiol 1998, 148:1187-1194.
46. Stevens J, Keil JE, Rust PF, et al.: Body mass index and body girths as predictors of mortality in black and white men. Am J Epidemiol 1992, 135:1137-1146.
47. Stevens J, Keil JE, Rust PF, et al.: Body mass index and body girths as predictors of mortality in black and white women. Arch Intern Med 1992, 152:1257-1262.
48. Canoy D, Boekholdt SM, Wareham N, et al.: Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 2007, 116:2933-2943. This population-based prospective study examines the nature of the association between fat distribution and CHD risk in both men and women in more detail. The investigators are also the first to report the importance of hip circumference as an independent predictor of lower CHD risk.
49. Whitlock G, Lewington S, Sherliker P, et al.: Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. Using data from various prospective cohort studies involving almost 1 million participants, the investigators were able to examine risk for all-cause and cause-specific mortality across the whole range of distribution of BMI.
50. Rexrode KM, Carey VJ, Hennekens CH, et al.: Abdominal adiposity and coronary heart disease in women. JAMA 1998, 280:1843-1848.
51. Aekplakorn W, Pakpeankitwatana V, Lee CM, et al.: Abdominal obesity and coronary heart disease in Thai men. Obesity (Silver Spring) 2007, 15:1036-1042.
52. Canoy D, Luben R, Welch A, et al.: Fat distribution, body mass index and blood pressure in 22,090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study. J Hypertens 2004, 22:2067-2074.
53. Canoy D, Wareham N, Luben R, et al.: Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20,021 British men and women: results from the EPIC-Norfolk population-based cohort study. Atherosclerosis 2006, 189:420-427.
54. Wiklund P, Toss F, Weinehall L, et al.: Abdominal and gynoid fat mass are associated with cardiovascular risk factors in men and women. J Clin Endocrinol Metab 2008, 93:4360-4366.
55. Heitmann BL, Frederiksen P: Thigh circumference and risk of heart disease and premature death: prospective cohort study. BMJ 2009, 339:b3292.
56. Despres JP: CVD risk assessment: do we need the metabolic syndrome or better global cardiometabolic risk calculators? Int J Obes (Lond) 2008, 32:S1-S4.
57. Klein S, Allison DB, Heymsfield SB, et al.: Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring) 2007, 15:1061-1067.
58. Alberti KG, Eckel RH, Grundy SM, et al.: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. The use of different definitions for metabolic syndrome espoused by different professional societies may have confused researchers and clinicians alike. In this report, a consensus has finally been achieved to use a standarized definition of metabolic syndrome. More importantly, abdominal adiposity is considered in this consensus to be one of the main features of the syndrome.
59. Drolet B, Simard C, Poirier P: Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs. Am J Cardiovasc Drugs 2007, 7:273-288.
60. Slentz CA, Duscha BD, Johnson JL, et al.: Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-a randomized controlled study. Arch Intern Med 2004, 164:31-39.
61. Canoy D, Wareham N, Luben R, et al.: Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res 2005, 13:1466-1475.
62. Lloyd-Jones D, Adams R, Carnethon M, et al.: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.